Genetic Polymorphism in CYP2D6 and its Association with the Safety and Efficacy of Fluvoxamine in Patients with Major Depressive Disorder . Precision Medicine Communications, [S. l.], v. 3, n. 1, p. 43–49, 2023. DOI: 10.55627/pmc.003.01.0301. Disponível em: https://rootspress.org/journals/index.php/PMC/article/view/301. Acesso em: 8 may. 2026.